Tenax Therapeutics Inc
F:YBOC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
Tenax Therapeutics Inc
F:YBOC
|
US |
|
Petmed Express Inc
NASDAQ:PETS
|
US |
|
A
|
Allied Gold Corp
TSX:AAUC
|
CA |
|
B
|
BioCryst Pharmaceuticals Inc
XMUN:BO1
|
US |
|
A
|
Abliva AB
F:NTP
|
SE |
|
M
|
Maxell Ltd
F:0H2
|
JP |
|
Eastern Bankshares Inc
F:EB0
|
US |
|
Emerald Holding Inc
NYSE:EEX
|
US |
|
Bumi Resources Minerals Tbk PT
F:BUR
|
ID |
|
C
|
Camtek Ltd
SWB:CMZ
|
IL |
|
S
|
Southwestern Energy Co
SWB:SW5
|
US |
Wall St Price Targets
YBOC Price Targets Summary
Tenax Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
YBOC is 0.247 EUR with a low forecast of 0.176 EUR and a high forecast of 0.351 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is YBOC's stock price target?
Price Target
0.247
EUR
According to Wall Street analysts, the average 1-year price target for
YBOC is 0.247 EUR with a low forecast of 0.176 EUR and a high forecast of 0.351 EUR.